Inhibiting oestrogen signalling in pulmonary arterial hypertension: sex, drugs and research
dc.contributor.author | Lahm, Tim | |
dc.contributor.author | Kawut, Steven M. | |
dc.contributor.department | Medicine, School of Medicine | en_US |
dc.date.accessioned | 2018-03-09T21:44:31Z | |
dc.date.available | 2018-03-09T21:44:31Z | |
dc.date.issued | 2017-08-03 | |
dc.description.abstract | Pulmonary arterial hypertension (PAH) is a sexually dimorphic disease that affects women more than men. Several pre-clinical and clinical studies identified 17β-oestradiol (E2), the most abundant female sex hormone, and/or its metabolite 16α-hydroxyoestrone as disease mediators in PAH (reviewed by Lahm et al. [1], and Foderaro and Venteuolo [2]). A recent case–control study even demonstrated significantly higher levels of E2 in men with PAH compared to controls [3]., Inhibition of oestrogen signalling in PAH is currently being studied clinically but several questions remain http://ow.ly/G7xK30cPN5M | en_US |
dc.eprint.version | Final published version | en_US |
dc.identifier.citation | Lahm, T., & Kawut, S. M. (2017). Inhibiting oestrogen signalling in pulmonary arterial hypertension: sex, drugs and research. The European Respiratory Journal, 50(2). https://doi.org/10.1183/13993003.00983-2017 | en_US |
dc.identifier.issn | 0903-1936 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/15428 | |
dc.language.iso | en_US | en_US |
dc.publisher | European Respiratory Society | en_US |
dc.relation.isversionof | 10.1183/13993003.00983-2017 | en_US |
dc.relation.journal | The European Respiratory Journal | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | PMC | en_US |
dc.subject | oestrogen | en_US |
dc.subject | pulmonary arteries | en_US |
dc.subject | sex | en_US |
dc.subject | hypertension | en_US |
dc.subject | drugs | en_US |
dc.title | Inhibiting oestrogen signalling in pulmonary arterial hypertension: sex, drugs and research | en_US |
dc.type | Article | en_US |
ul.alternative.fulltext | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593373/ | en_US |